Click here to read the Cover Story, "When to use which MIGS approach is a nuanced decision."
The withdrawal of the CyPass (Alcon) removed the one drainage device that shunted fluid to the suprachoroidal space, and it has not been replaced to date. This mechanism was unique and provided a significant benefit for many patients with uncontrolled IOP. Corneal endothelial health is important, and the safety data elucidating the long-term risk in some patients should not be discounted. In my opinion, solely as a practitioner and not as a regulatory (Read more...)
Uncategorized